↓ Skip to main content

Cochrane Database of Systematic Reviews

Duloxetine for treating painful neuropathy or chronic pain

Overview of attention for article published in this source, October 2009
Altmetric Badge

Mentioned by

1 policy source
1 X user
1 Facebook page
1 Wikipedia page


173 Dimensions

Readers on

105 Mendeley
Duloxetine for treating painful neuropathy or chronic pain
Published by
John Wiley & Sons, Ltd, October 2009
DOI 10.1002/14651858.cd007115.pub2
Pubmed ID

Lunn, Michael PT, Hughes, Richard AC, Wiffen, Philip J


Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive disorders, urinary stress incontinence and the management of neuropathic pain associated with diabetic peripheral neuropathy. A number of trials have been conducted to investigate the use of duloxetine in neuropathic and nociceptive painful conditions.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
United States 2 2%
Spain 1 <1%
Hong Kong 1 <1%
Unknown 99 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 16%
Researcher 16 15%
Student > Bachelor 10 10%
Student > Postgraduate 10 10%
Student > Ph. D. Student 10 10%
Other 17 16%
Unknown 25 24%
Readers by discipline Count As %
Medicine and Dentistry 34 32%
Psychology 11 10%
Nursing and Health Professions 8 8%
Agricultural and Biological Sciences 4 4%
Chemistry 4 4%
Other 16 15%
Unknown 28 27%